Integra Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Integra LifeSciences Holdings
IART Stock  USD 24.12  0.60  2.43%   
Integra LifeSciences financial statements provide useful quarterly and yearly information to potential Integra LifeSciences Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Integra LifeSciences financial statements helps investors assess Integra LifeSciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Integra LifeSciences' valuation are summarized below:
Gross Profit
932.5 M
Profit Margin
(0)
Market Capitalization
1.9 B
Enterprise Value Revenue
2.1806
Revenue
1.6 B
There are currently one hundred twenty fundamental trends for Integra LifeSciences that can be evaluated and compared over time across competitors. All traders should confirm Integra LifeSciences' regular fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 1 B in 2025. Enterprise Value is likely to gain to about 442.9 M in 2025

Integra LifeSciences Total Revenue

1.86 Billion

Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra LifeSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 149.1 M, Interest Expense of 62 M or Total Revenue of 1.9 B, as well as many indicators such as Price To Sales Ratio of 1.03, Dividend Yield of 3.0E-4 or PTB Ratio of 1.07. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.
  
Check out the analysis of Integra LifeSciences Correlation against competitors.

Integra LifeSciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.6 B4.3 B2.6 B
Slightly volatile
Other Current Liabilities212.9 M202.7 M129.5 M
Slightly volatile
Total Current Liabilities370.7 M353 M234.6 M
Slightly volatile
Total Stockholder Equity1.9 B1.8 B1.1 B
Slightly volatile
Property Plant And Equipment Net599.4 M570.8 M315.7 M
Slightly volatile
Accounts Payable111.5 M106.2 M64.1 M
Slightly volatile
Cash333.8 M317.9 M214.1 M
Slightly volatile
Non Current Assets Total3.3 B3.1 B1.9 B
Slightly volatile
Cash And Short Term Investments373.2 M355.5 M221 M
Slightly volatile
Net Receivables313.1 M298.2 M196.9 M
Slightly volatile
Common Stock Shares Outstanding67.2 M92.4 M72.4 M
Slightly volatile
Liabilities And Stockholders Equity4.6 B4.3 B2.6 B
Slightly volatile
Non Current Liabilities Total2.3 B2.2 B1.3 B
Slightly volatile
Inventory470.5 M448 M273.5 M
Slightly volatile
Other Current Assets120.8 M115 M78.3 M
Slightly volatile
Other Stockholder Equity467.2 M753.5 M649.8 M
Slightly volatile
Total Liabilities2.6 B2.5 B1.5 B
Slightly volatile
Property Plant And Equipment Gross1 B993.4 M433.1 M
Slightly volatile
Total Current Assets1.3 B1.2 B778.9 M
Slightly volatile
Intangible Assets1.3 B1.2 B774.4 M
Slightly volatile
Short and Long Term Debt Total2 B1.9 B1.2 B
Slightly volatile
Common Stock Total Equity528.7 K1 M671 K
Slightly volatile
Short Term Debt32.6 M34.3 M76.7 M
Very volatile
Common Stock547.5 K1 M672.7 K
Slightly volatile
Other Liabilities243.7 M232.1 M121.6 M
Slightly volatile
Other Assets69 M72.6 M277.7 M
Pretty Stable
Long Term Debt1.8 B1.7 B1 B
Slightly volatile
Property Plant Equipment375.9 M358 M251.3 M
Slightly volatile
Current Deferred Revenue5.3 M9.8 M5.7 M
Slightly volatile
Good Will1.3 B1.2 B725.1 M
Slightly volatile
Retained Earnings Total Equity1.1 B1 B491 M
Slightly volatile
Long Term Debt Total1 B1.5 B989.4 M
Slightly volatile
Capital Surpluse1 B1.5 B995.7 M
Slightly volatile
Non Current Liabilities Other150.3 M229.9 M143.3 M
Slightly volatile
Deferred Long Term Asset Charges8.1 M6.2 M9.1 M
Slightly volatile
Short and Long Term Debt12.4 M13.1 M68.7 M
Very volatile
Long Term Investments3.5 M6.2 M3.5 M
Slightly volatile
Net Invested Capital3.3 B3.6 B3 B
Slightly volatile
Net Working Capital747.1 M863.7 M604.8 M
Slightly volatile
Capital Stock984.5 K1 M902.5 K
Slightly volatile
Capital Lease Obligations147.4 M209.5 M125.9 M
Slightly volatile

Integra LifeSciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization149.1 M142 M79.8 M
Slightly volatile
Total Revenue1.9 B1.8 B1.2 B
Slightly volatile
Gross Profit1.1 B1 B727.3 M
Slightly volatile
Other Operating Expenses1.7 B1.6 B1.1 B
Slightly volatile
Research Development210.8 M200.8 M87.5 M
Slightly volatile
EBITDA330.9 M315.1 M183.2 M
Slightly volatile
Cost Of Revenue788.7 M751.2 M465.6 M
Slightly volatile
Total Operating Expenses1 B961.8 M633.3 M
Slightly volatile
Selling General Administrative792.9 M755.1 M531.7 M
Slightly volatile
Non Recurring61.4 M74.7 M60.8 M
Slightly volatile
Interest Income10.1 M19.8 M14.4 M
Slightly volatile
Reconciled Depreciation107.5 M142 M97.3 M
Slightly volatile

Integra LifeSciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow551.4 M525.2 M231.4 M
Slightly volatile
Depreciation149.1 M142 M88.9 M
Slightly volatile
Capital Expenditures80.7 M76.9 M57.5 M
Slightly volatile
End Period Cash Flow333.8 M317.9 M214.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.031.08453.1152
Slightly volatile
Dividend Yield3.0E-43.0E-43.0E-4
Slightly volatile
PTB Ratio1.071.13032.9797
Slightly volatile
Days Sales Outstanding68.8961.728360.0537
Slightly volatile
Book Value Per Share21.0720.06614.3518
Slightly volatile
Capex To Depreciation1.050.74110.8239
Slightly volatile
PB Ratio1.071.13032.9797
Slightly volatile
EV To Sales1.011.06523.6867
Slightly volatile
Inventory Turnover1.941.931.781
Very volatile
Days Of Inventory On Hand170196211
Slightly volatile
Payables Turnover10.648.148.5839
Slightly volatile
Sales General And Administrative To Revenue0.570.540.4983
Pretty Stable
Research And Ddevelopement To Revenue0.140.07160.096
Slightly volatile
Capex To Revenue0.07290.06480.067
Slightly volatile
Cash Per Share3.733.55242.7457
Slightly volatile
Days Payables Outstanding32.1646.4346.1059
Pretty Stable
Intangibles To Total Assets0.340.57080.5054
Slightly volatile
Current Ratio1.111.1733.3329
Slightly volatile
Receivables Turnover4.745.9136.1252
Slightly volatile
Graham Number8.826.380514.7566
Slightly volatile
Shareholders Equity Per Share21.0720.06614.3518
Slightly volatile
Debt To Equity0.130.13940.8619
Pretty Stable
Capex Per Share1.421.35590.8281
Slightly volatile
Revenue Per Share21.9620.913215.6519
Slightly volatile
Interest Debt Per Share1.791.879512.623
Slightly volatile
Debt To Assets0.05070.05330.3667
Pretty Stable
Short Term Coverage Ratios3.482.67068.6924
Slightly volatile
Operating Cycle58.6461.7283244
Slightly volatile
Price Book Value Ratio1.071.13032.9797
Slightly volatile
Days Of Payables Outstanding32.1646.4346.1059
Pretty Stable
Company Equity Multiplier1.592.61272.2203
Pretty Stable
Long Term Debt To Capitalization0.09260.09750.4146
Slightly volatile
Total Debt To Capitalization0.120.12230.4315
Pretty Stable
Debt Equity Ratio0.130.13940.8619
Pretty Stable
Quick Ratio0.670.70772.1594
Slightly volatile
Cash Ratio0.250.26720.8939
Slightly volatile
Cash Conversion Cycle58.6461.7283203
Slightly volatile
Days Of Inventory Outstanding170196211
Slightly volatile
Days Of Sales Outstanding68.8961.728360.0537
Slightly volatile
Cash Flow Coverage Ratios0.40.60070.1973
Slightly volatile
Price To Book Ratio1.071.13032.9797
Slightly volatile
Fixed Asset Turnover2.782.92953.8535
Slightly volatile
Debt Ratio0.05070.05330.3667
Pretty Stable
Cash Flow To Debt Ratio0.40.60070.1973
Slightly volatile
Price Sales Ratio1.031.08453.1152
Slightly volatile
Asset Turnover0.580.39890.5083
Slightly volatile
Gross Profit Margin0.50.520.6074
Slightly volatile
Price Fair Value1.071.13032.9797
Slightly volatile

Integra LifeSciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1 B963.6 M1 B
Slightly volatile
Enterprise Value442.9 M421.8 M442.2 M
Slightly volatile

Integra Fundamental Market Drivers

Forward Price Earnings8.8496
Cash And Short Term Investments309.1 M

Integra Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Integra LifeSciences Financial Statements

Integra LifeSciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Integra LifeSciences investors may analyze each financial statement separately, they are all interrelated. The changes in Integra LifeSciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Integra LifeSciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue9.8 M5.3 M
Total Revenue1.8 B1.9 B
Cost Of Revenue751.2 M788.7 M
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.54  0.57 
Research And Ddevelopement To Revenue 0.07  0.14 
Capex To Revenue 0.06  0.07 
Revenue Per Share 20.91  21.96 
Ebit Per Revenue 0.02  0.02 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Integra Stock Analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY